0
     

Report Added
Report already added
North America (NAFTA) Healthcare Providers Market Summary, Competitive Analysis and Forecast, 2017-2026

North America (NAFTA) Healthcare Providers Market Summary, Competitive Analysis and Forecast, 2017-2026

Summary

The NAFTA Healthcare Providers industry profile provides top-line qualitative and quantitative summary information including: Sector size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the Sector.

Key Highlights

- The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The healthcare providers industry within the NAFTA countries had a total market value of $4,326.8 billion in 2021.The Canada was the fastest growing country, with a CAGR of 5.8% over the 2017-21 period.
- Within the healthcare providers industry, the US is the leading country among the NAFTA bloc, with market revenues of $4,016.6 billion in 2021. This was followed by Canada and Mexico, with a value of $245.7 and $64.5 billion, respectively.
- The US is expected to lead the healthcare providers industry in the NAFTA bloc, with a value of $5,288.5 billion in 2026, followed by Canada and Mexico with expected values of $318.5 and $80.4 billion, respectively.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the NAFTA healthcare providers Sector
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the NAFTA healthcare providers Sector
- Leading company profiles reveal details of key healthcare providers Sector players’ NAFTA operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the NAFTA healthcare providers Sector with five year forecasts
- Compares data from the US, Canada and Mexico, alongside individual chapters on each country

Reasons to Buy

- What was the size of the NAFTA healthcare providers Sector by value in 2021?
- What will be the size of the NAFTA healthcare providers Sector in 2026?
- What factors are affecting the strength of competition in the NAFTA healthcare providers Sector?
- How has the Sector performed over the last five years?
- What are the main segments that make up the NAFTA healthcare providers Sector?

Table of Contents

1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 NAFTA Healthcare Providers
2.1. Industry Outlook
3 Healthcare Providers in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Healthcare Providers in Mexico
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Healthcare Providers in The United States
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Company Profiles
9.1. KPJ Healthcare Berhad
9.2. Medica Sur SAB de CV
9.3. HCA Healthcare, Inc.
10 Appendix
10.1. Methodology
10.2. About MarketLine

List of Tables
Table 1: NAFTA countries healthcare providers industry, revenue ($bn), 2017-26
Table 2: NAFTA countries healthcare providers industry, revenue ($bn), 2017-21
Table 3: NAFTA countries healthcare providers industry forecast, revenue ($bn), 2021-26
Table 4: Canada healthcare providers sector value: $ billion, 2017-21
Table 5: Canada healthcare providers sector category segmentation: $ billion, 2021
Table 6: Canada healthcare providers sector geography segmentation: $ billion, 2021
Table 7: Canada healthcare providers sector distribution: % share, by value, 2021
Table 8: Canada healthcare providers sector value forecast: $ billion, 2021-26
Table 9: Canada size of population (million), 2017-21
Table 10: Canada gdp (constant 2005 prices, $ billion), 2017-21
Table 11: Canada gdp (current prices, $ billion), 2017-21
Table 12: Canada inflation, 2017-21
Table 13: Canada consumer price index (absolute), 2017-21
Table 14: Canada exchange rate, 2017-21
Table 15: Mexico healthcare providers sector value: $ billion, 2017-21
Table 16: Mexico healthcare providers sector category segmentation: $ billion, 2021
Table 17: Mexico healthcare providers sector geography segmentation: $ billion, 2021
Table 18: Mexico healthcare providers sector distribution: % share, by value, 2021
Table 19: Mexico healthcare providers sector value forecast: $ billion, 2021-26
Table 20: Mexico size of population (million), 2017-21
Table 21: Mexico gdp (constant 2005 prices, $ billion), 2017-21
Table 22: Mexico gdp (current prices, $ billion), 2017-21
Table 23: Mexico inflation, 2017-21
Table 24: Mexico consumer price index (absolute), 2017-21
Table 25: Mexico exchange rate, 2017-21
Table 26: United States healthcare providers sector value: $ billion, 2017-21
Table 27: United States healthcare providers sector category segmentation: $ billion, 2021
Table 28: United States healthcare providers sector geography segmentation: $ billion, 2021
Table 29: United States healthcare providers sector distribution: % share, by value, 2021
Table 30: United States healthcare providers sector value forecast: $ billion, 2021-26
Table 31: United States size of population (million), 2017-21
Table 32: United States gdp (constant 2005 prices, $ billion), 2017-21
Table 33: United States gdp (current prices, $ billion), 2017-21
Table 34: United States inflation, 2017-21
Table 35: United States consumer price index (absolute), 2017-21
Table 36: United States exchange rate, 2017-21
Table 37: KPJ Healthcare Berhad: key facts
Table 38: KPJ Healthcare Berhad: Annual Financial Ratios
Table 39: KPJ Healthcare Berhad: Key Employees
Table 40: KPJ Healthcare Berhad: Key Employees Continued
Table 41: Medica Sur SAB de CV: key facts
Table 42: Medica Sur SAB de CV: Annual Financial Ratios
Table 43: Medica Sur SAB de CV: Key Employees
Table 44: HCA Healthcare, Inc.: key facts
Table 45: HCA Healthcare, Inc.: Annual Financial Ratios
Table 46: HCA Healthcare, Inc.: Key Employees
Table 47: HCA Healthcare, Inc.: Key Employees Continued

List of Figures
Figure 1: NAFTA countries healthcare providers industry, revenue ($bn), 2017-26
Figure 2: NAFTA countries healthcare providers industry, revenue ($bn), 2017-21
Figure 3: NAFTA countries healthcare providers industry forecast, revenue ($bn), 2021-26
Figure 4: Canada healthcare providers sector value: $ billion, 2017-21
Figure 5: Canada healthcare providers sector category segmentation: % share, by value, 2021
Figure 6: Canada healthcare providers sector geography segmentation: % share, by value, 2021
Figure 7: Canada healthcare providers sector distribution: % share, by value, 2021
Figure 8: Canada healthcare providers sector value forecast: $ billion, 2021-26
Figure 9: Forces driving competition in the healthcare providers sector in Canada, 2021
Figure 10: Drivers of buyer power in the healthcare providers sector in Canada, 2021
Figure 11: Drivers of supplier power in the healthcare providers sector in Canada, 2021
Figure 12: Factors influencing the likelihood of new entrants in the healthcare providers sector in Canada, 2021
Figure 13: Factors influencing the threat of substitutes in the healthcare providers sector in Canada, 2021
Figure 14: Drivers of degree of rivalry in the healthcare providers sector in Canada, 2021
Figure 15: Mexico healthcare providers sector value: $ billion, 2017-21
Figure 16: Mexico healthcare providers sector category segmentation: % share, by value, 2021
Figure 17: Mexico healthcare providers sector geography segmentation: % share, by value, 2021
Figure 18: Mexico healthcare providers sector distribution: % share, by value, 2021
Figure 19: Mexico healthcare providers sector value forecast: $ billion, 2021-26
Figure 20: Forces driving competition in the healthcare providers sector in Mexico, 2021
Figure 21: Drivers of buyer power in the healthcare providers sector in Mexico, 2021
Figure 22: Drivers of supplier power in the healthcare providers sector in Mexico, 2021
Figure 23: Factors influencing the likelihood of new entrants in the healthcare providers sector in Mexico, 2021
Figure 24: Factors influencing the threat of substitutes in the healthcare providers sector in Mexico, 2021
Figure 25: Drivers of degree of rivalry in the healthcare providers sector in Mexico, 2021
Figure 26: United States healthcare providers sector value: $ billion, 2017-21
Figure 27: United States healthcare providers sector category segmentation: % share, by value, 2021
Figure 28: United States healthcare providers sector geography segmentation: % share, by value, 2021
Figure 29: United States healthcare providers sector distribution: % share, by value, 2021
Figure 30: United States healthcare providers sector value forecast: $ billion, 2021-26
Figure 31: Forces driving competition in the healthcare providers sector in the United States, 2021
Figure 32: Drivers of buyer power in the healthcare providers sector in the United States, 2021
Figure 33: Drivers of supplier power in the healthcare providers sector in the United States, 2021
Figure 34: Factors influencing the likelihood of new entrants in the healthcare providers sector in the United States, 2021
Figure 35: Factors influencing the threat of substitutes in the healthcare providers sector in the United States, 2021
Figure 36: Drivers of degree of rivalry in the healthcare providers sector in the United States, 2021

Report Title: North America (NAFTA) Healthcare Providers Market Summary, Competitive Analysis and Forecast, 2017-2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Veterinary Pain Management Market by Product (Drug (NSAIDs, Opioids), Route of Administration (Oral, Parenteral), Device (Laser)), Application (Joint Pain, Cancer), Animal (Companion and Livestock), End User (Hospital, Pharmacy) - Global Forecast to 2027

Veterinary Pain Management Market by Product (Drug (NSAIDs, Opioids), Route of Administration (Oral, Parenteral), Device (Laser)), Application (Joint Pain, Cancer), Animal (Companion and Livestock), End User (Hospital, Pharmacy) - Global Forecast to 2027

Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, MCOT, ECG, ICP, ILRs, Multi-parameter Monitoring, Weight Monitoring), End-User (Hospital, ASCs) - Global Forecast to 2027

Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, MCOT, ECG, ICP, ILRs, Multi-parameter Monitoring, Weight Monitoring), End-User (Hospital, ASCs) - Global Forecast to 2027

US Transdermal Patch Market Opportunity & Clinical Trials Insight 2028

US Transdermal Patch Market Opportunity & Clinical Trials Insight 2028

Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity